Skip to main content
. 2020 Dec 14;147(3):755–765. doi: 10.1007/s00432-020-03482-6

Table 2.

Uni- and multivariable analysis of overall survival for mRNA expression, CNV and protein expression of YY1, CP2 and the YY1CP2 score

Univariable Multivariable
HR 95% CI p value HR 95% CI p value
mRNA expression (n = 510)
 YY1 high vs. low 1.35 1.03–1.78 0.030 1.26 0.94–1.68 0.127
 YY1 z score 1.08 0.99–1.19 0.068 1.05 0.94–1.18 0.365
 CP2 high vs. low 1.11 0.84–1.45 0.465 1.24 0.94–1.65 0.133
 CP2 z score 1.07 0.95–1.20 0.262 1.14 1.00–1.29 0.049
 YY1CP2 score 1.55 1.16–2.05 0.003 1.60 1.19–2.16 0.002
mRNA expression—interaction analysis (n = 510)
 YY1 + (ref. YY1 − CP2 −) 0.97 0.66–1.43 0.892 0.89 0.59–1.34 0.570
 CP2 + (ref. YY1 − CP2 −) 0.74 0.48–1.13 0.165 0.82 0.52–1.29 0.398
 YY1 + CP2 + 1.96 1.12–3.43 0.018 1.99 1.11–3.58 0.021
CNV (n = 510)
 YY1 high vs. low 1.33 1.02–1.75 0.036 1.19 0.89–1.59 0.230
 YY1 values 1.20 0.63–2.31 0.582 1.10 0.57–2.12 0.778
 CP2 high vs. low 0.83 0.63–1.09 0.185 0.90 0.68–1.20 0.479
 CP2 values 0.88 0.30–2.58 0.813 1.16 0.37–3.58 0.803
 YY1CP2 score 1.10 0.81–1.49 0.555 1.07 0.78–1.48 0.669
Protein expression (n = 102)
 YY1 0.66 0.31–1.40 0.281 0.63 0.28–1.44 0.275
 CP2 0.90 0.52–1.57 0.712 1.05 0.59–1.88 0.861
 YY1CP2 score 0.60 0.27–1.33 0.207 0.66 0.29–1.51 0.320

p value below 0.05 was considered significant and highlighted (bold)

mRNA levels were analyzed for their expression level (high vs. low) and per change of z score unit. Multivariable analysis was adjusted for staging, HPV status and smoker status. For mRNA expression, the pair-wise interaction for high expressions of YY1 and CP2 was calculated. A p value below 0.05 was considered significant and highlighted (bold).

HR, hazard ratio, CI confidence interval, ref. reference, + high expression, − low expression